Morgan Stanley’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
|
|||||
|
2025
Q1 | $10.9M | Buy |
|
|||||
|
2024
Q4 | $18.1M | Sell |
|
|||||
|
2024
Q3 | $10.5M | Sell |
|
|||||
|
2024
Q2 | $13.8M | Sell |
|
|||||
|
2024
Q1 | $27.5M | Sell |
|
|||||
|
2023
Q4 | $42.4M | Buy |
|
|||||
|
2023
Q3 | $17.6M | Buy |
|
|||||
|
2023
Q2 | $33.6M | Buy |
|
|||||
|
2023
Q1 | $29M | Sell |
|
|||||
|
2022
Q4 | $36.1M | Sell |
|
|||||
|
2022
Q3 | $71M | Sell |
|
|||||
|
2022
Q2 | $71.5M | Buy |
|
|||||
|
2022
Q1 | $60.5M | Sell |
|
|||||
|
2021
Q4 | $62M | Sell |
|
|||||
|
2021
Q3 | $103M | Buy |
|
|||||
|
2021
Q2 | $191M | Sell |
|
|||||
|
2021
Q1 | $163M | Sell |
|
|||||
|
2020
Q4 | $234M | Buy |
|
|||||
|
2020
Q3 | $147M | Sell |
|
|||||
|
2020
Q2 | $79.5M | Buy |
|
|||||
|
2020
Q1 | $83M | Sell |
|
|||||
|
2019
Q4 | $114M | Buy |
|
|||||
|
2019
Q3 | $18.2M | Buy |
|
|||||
|
2019
Q2 | $6.45M | Buy |
|
|||||
|
2019
Q1 | $4.14M | Sell |
|
|||||
|
2018
Q4 | $6.62M | Sell |
|
|||||
|
2018
Q3 | $13.4M | Sell |
|
|||||
|
2018
Q2 | $8.25M | Buy |
|
|||||
|
2018
Q1 | $5.55M | Buy |
|
|||||
|
2017
Q4 | $4.87M | Buy |
|
|||||
|
2017
Q3 | $4.5M | Buy |
|
|||||
|
2017
Q2 | $2.96M | Buy |
|
|||||
|
2017
Q1 | $875K | Sell |
|
|||||
|
2016
Q4 | $1.62M | Buy |
|
|||||
|
2016
Q3 | $434K | Buy |
|
|||||
|
2016
Q2 | $460K | Sell |
|
|||||
|
2016
Q1 | $3.83M | Sell |
|
|||||
|
2015
Q4 | $9.62M | Buy |
|